Human tetanus immunoglobulin

DRUG2 trials

Sponsors

Oxford University Clinical Research Unit, Vietnam, Lanzhou Institute of Biological Products Co., Ltd

Conditions

Tetanus

Phase 1

Intrathecal Tetanus Immunoglobulin to Treat Tetanus

CompletedNCT02999815

Oxford University Clinical Research Unit, VietnamTetanus

Start: 2017-02-13End: 2020-05-01Updated: 2020-05-29

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection

Enrolling by invitationNCT07149454

Lanzhou Institute of Biological Products Co., LtdTetanus

Start: 2025-08-18End: 2026-06-24Target: 68Updated: 2026-01-28

Related Papers

Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial.

2022-06-019 citations

Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial.

2018-11-0511 citations